Literature DB >> 23455738

Arterial embolization of a bleeding gastric Dieulafoy lesion: a case report.

M Y Mohd Rizal1, N R Kosai, P A Sutton, Z Rozman, J Razman, H Harunarashid, S Das.   

Abstract

Dieulafoy's lesion is one of an unusual cause of upper gastrointestinal bleeding (U GIB). Endoscopic intervention has always been a preferred non-surgical method in treating UGIB including bleeding from Dieulafoy's lesion. Owing to recent advances in angiography, arterial embolization has become a popular alternative in non- variceal UGIB especially in cases with failed endoscopic treatment. However, managing bleeding Dieulafoy's with selective arterial embolization as the first line of treatment has not been exclusively practiced. We hereby, report a case of bleeding Dieulafoy lesion which had been primarily treated with arterial embolization.

Entities:  

Mesh:

Year:  2013        PMID: 23455738     DOI: 10.7417/T.2013.1506

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  4 in total

Review 1.  Gastrointestinal bleeding from Dieulafoy's lesion: Clinical presentation, endoscopic findings, and endoscopic therapy.

Authors:  Borko Nojkov; Mitchell S Cappell
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

2.  The efficiency of endoclips in maintaining the gastrointestinal bleeding-related Dieulafoy's lesion.

Authors:  Fatih Karaahmet; Serta Kılıncalp; Yusuf Coskun; Mevlut Hamamci; Hakan Akinci; Yusuf Ustun; Zahide Simsek; Elife Erarslan; Sahin Coban; Ilhami Yuksel
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

3.  Longitudinal Gastrectomy for Nonbariatric Indications.

Authors:  Oluwatobi O Onafowokan; Aboubakr Khairat; Mohammad Jamal; Hemant Chatrath; Hugo J R Bonatti
Journal:  Minim Invasive Surg       Date:  2021-05-06

4.  Superselective arterial embolization of the superior mesenteric artery for the treatment of gastrointestinal hemorrhage following allogeneic hematopoietic stem cell transplantation.

Authors:  Run-Zhe Chen; Gang Zhao; Nan Jin; Bao-An Chen; Jia-Hua Ding
Journal:  Patient Prefer Adherence       Date:  2014-11-13       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.